Business
Semler Scientific® to Release Third Quarter 2025 Financial Results
Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced that due to its pending transaction with Strive, Inc., the company will not be hosting a conference call or providing an accompanying earnings presentation in conjunction with its third quarter 2025 financial results.
About this update from Strive, Inc.
[{"type":"text","content":"CAMPBELL, Calif., Oct. 28, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced that due to its pending transaction with Strive, Inc., the company will not be hosting a conference call or providing an accompanying earnings presentation in conjunction with its third quarter 2025 financial results.","length":480,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Semler Scientific, Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Semler Scientific, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":79,"url":"https://media.zenfs.com/en/prnewswire.com/be20591d32ed1e9790f351eb9faba96e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mgj.3Ldj88kPzcPFi0WTJg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEzOTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/be20591d32ed1e9790f351eb9faba96e","width":400,"height":79}},"href":"https://mma.prnewswire.com/media/2394289/Semler_Logo_registered.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Semler Scientific intends to file its Quarterly Report on Form 10-Q for the period ended September 30, 2025, on or about November 12, 2025.","length":139,"tagName":"p"},{"type":"text","content":"About Semler Scientific, Inc.:","length":35,"tagName":"p"},{"type":"text","content":"Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc., develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo®, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease. Additional information about Semler ...